[go: up one dir, main page]

PE20010829A1 - Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas - Google Patents

Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas

Info

Publication number
PE20010829A1
PE20010829A1 PE2001000034A PE2001000034A PE20010829A1 PE 20010829 A1 PE20010829 A1 PE 20010829A1 PE 2001000034 A PE2001000034 A PE 2001000034A PE 2001000034 A PE2001000034 A PE 2001000034A PE 20010829 A1 PE20010829 A1 PE 20010829A1
Authority
PE
Peru
Prior art keywords
same
load
pets
helicobacter
lactobacillus
Prior art date
Application number
PE2001000034A
Other languages
English (en)
Inventor
Olivier De Rte De Cojonnex Ballevre
Irene Corthesy-Theulaz
Marc Yves Adolphe Esnslen
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170924&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20010829(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PE20010829A1 publication Critical patent/PE20010829A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/805—Pet food for dog, cat, bird, or fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE REFIERE A UNA COMPOSICION ASOCIADA A UN SOPORTE INGERIBLE O UNA MATRIZ FARMACEUTICA, QUE COMPRENDE UNA CANTIDAD DE 10 3 A 10 14 UNIDADES FORMADORAS DE COLONIA AL DIA, DE UNA CEPA DE BACTERIAS LACTICAS, AISLADA Y/O SUS METABOLITOS O SU MEDIO DE CRECIMIENTO FERMENTADO; DONDE, LAS BACTERIAS SON AISLADAS Y SELECCIONADAS POR SU CAPACIDAD PARA DESPLEGAR UNA PODEROSA ACTIVIDAD BACTERICIDA ANTI-HELICOBACTER IN VITRO; SELECCIONANDOSE LAS CEPAS DE LAS MISMAS DE: LACTOBACILLUS JOHNSONII; LACTOBACILLUS REUTERII; LACTOBACILLUS PARACASEI, ENTRE OTROS. DICHA COMPOSICION REDUCE LA INFECCION Y LOS TRANSTORNOS RELACIONADOS A LA MISMA Y QUE ES PRODUCIDA POR ORGANISMOS SEMEJANTES AL HELICOBACTER GASTRICO EN EL TRACTO GASTROINTESTINAL DE LAS MASCOTAS, REDUCIENDO LA CARGA DE LOS MISMOS Y LA ACTIVIDAD DE LA UREASA EN EL FONDO EN 0,5 GRADOS
PE2001000034A 2000-01-18 2001-01-15 Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas PE20010829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00200179 2000-01-18

Publications (1)

Publication Number Publication Date
PE20010829A1 true PE20010829A1 (es) 2001-09-03

Family

ID=8170924

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000034A PE20010829A1 (es) 2000-01-18 2001-01-15 Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas

Country Status (18)

Country Link
US (1) US7910144B2 (es)
EP (1) EP1251747B1 (es)
JP (2) JP5148796B2 (es)
AR (1) AR027247A1 (es)
AT (1) ATE542434T1 (es)
AU (1) AU784898B2 (es)
BR (1) BR0016973A (es)
CA (1) CA2396958C (es)
CO (1) CO5280056A1 (es)
ES (1) ES2378811T3 (es)
MX (1) MXPA02007018A (es)
NO (1) NO330198B1 (es)
NZ (1) NZ519980A (es)
PE (1) PE20010829A1 (es)
PH (1) PH12000003631B1 (es)
UY (1) UY26545A1 (es)
WO (1) WO2001052667A2 (es)
ZA (1) ZA200206546B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
AU2002302478A1 (en) * 2001-03-30 2002-10-15 Societe Des Produits Nestle S.A. Methods and products for removing tartar from the teeth of a pet
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2007518400A (ja) * 2003-12-04 2007-07-12 バイオフィルムズ ストラテジーズ， インコーポレイテッド バイオフィルムの形成を防止、存在するバイオフィルムを減少、および細菌の個体群を減少させるための方法ならびに組成物
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
AU2006288252B2 (en) * 2005-09-08 2012-01-12 Kabushiki Kaisha Yakult Honsha Cholesterol absorption inhibitor
CA2673465A1 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
ITMI20091406A1 (it) * 2009-08-03 2011-02-04 Biotecnologie B T S R L Produzione di pellet contenenti sostanze termolabili
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2449889A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Rice pudding preparations containing probiotic micro-organisms
EP2797426A1 (en) * 2011-12-29 2014-11-05 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
EP2674162A1 (en) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
EA201491272A1 (ru) * 2012-05-29 2015-10-30 Данута Кружевска Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение
ITPD20130133A1 (it) * 2013-05-14 2014-11-15 Sanypet S P A Prodotto per l'alimentazione di cani affetti da disturbi infiammatori dell'intestino
JP6338206B2 (ja) * 2013-12-20 2018-06-06 雪印メグミルク株式会社 抗ヘリコバクター・ハイルマニー剤
JP6329206B2 (ja) * 2016-06-30 2018-05-23 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 消化管フローラを改良する組成物および方法
KR20180078458A (ko) * 2016-12-30 2018-07-10 이경문 동물 개체별 맞춤형 식료품 제공 방법
JP6482045B2 (ja) * 2018-01-30 2019-03-13 雪印メグミルク株式会社 抗ヘリコバクター・ハイルマニー剤
JP2019149977A (ja) * 2018-03-05 2019-09-12 今野 由梨 ペット用サプリメント及びその製造方法
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
EP3812452A4 (en) 2018-09-30 2021-11-03 Inner Mongolia Yili Industrial Group Co., Ltd. BIFIDOBACTERIUM LACTIS BL-99 AND ASSOCIATED APPLICATION
CN111616260A (zh) * 2020-06-04 2020-09-04 广州市中添生物科技有限公司 一种富含犬猫肠道绒毛修复因子的功能性益生菌制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
EP0862863B9 (en) * 1997-01-09 2009-08-12 Societe Des Produits Nestle S.A. Cereal product containing probiotics
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
JPH11171783A (ja) * 1997-08-15 1999-06-29 Vetoquinol Sa 所定の動物に関して細胞性免疫と体重増加を生じる濃度でのバクテリアの経口投与
JPH1192390A (ja) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc ストレス状態改善剤
CA2334370A1 (en) * 1998-06-05 1999-12-16 Nobuyuki Suzuki Lactic acid bacterium-containing compositions, drugs and foods
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations

Also Published As

Publication number Publication date
PH12000003631B1 (en) 2007-11-16
NO20023434D0 (no) 2002-07-17
NZ519980A (en) 2004-04-30
MXPA02007018A (es) 2002-12-13
JP5149346B2 (ja) 2013-02-20
UY26545A1 (es) 2001-07-31
US20030049240A1 (en) 2003-03-13
AR027247A1 (es) 2003-03-19
JP2011024583A (ja) 2011-02-10
US7910144B2 (en) 2011-03-22
BR0016973A (pt) 2002-10-15
WO2001052667A2 (en) 2001-07-26
EP1251747A2 (en) 2002-10-30
CA2396958C (en) 2009-11-17
ATE542434T1 (de) 2012-02-15
NO20023434L (no) 2002-08-20
JP2003520038A (ja) 2003-07-02
AU784898B2 (en) 2006-07-20
ZA200206546B (en) 2004-01-21
CA2396958A1 (en) 2001-07-26
CO5280056A1 (es) 2003-05-30
JP5148796B2 (ja) 2013-02-20
EP1251747B1 (en) 2012-01-25
NO330198B1 (no) 2011-03-07
WO2001052667A3 (en) 2002-05-02
AU4049401A (en) 2001-07-31
ES2378811T3 (es) 2012-04-18

Similar Documents

Publication Publication Date Title
PE20010829A1 (es) Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas
ATE335071T1 (de) Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung
Monteagudo-Mera et al. In vitro evaluation of physiological probiotic properties of different lactic acid bacteria strains of dairy and human origin
DE60237645D1 (de) Immunstimulierendes Mittel enthaltend eine Biomasse von methanotrophem Bakterium
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
UA42092C2 (uk) Штам молочнокислих бактерій bifidobacterium breve, штам молочнокислих бактерій bifidobacterium infantis, штам молочнокислих бактерій bifidobacterium longum для покращення кишкової флори, спосіб покращення кишкової флори
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
AR047066A1 (es) Metodos para usar lactobacilos probioticos para animales de compania
AR047064A1 (es) Lactobacilos probioticos para caninos y uso
PE20020232A1 (es) Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas
Portrait et al. A Fusobacterium mortiferum strain produces a bacteriocin‐like substance (s) inhibiting Salmonella enteritidis
BR0309347A (pt) Uso de uma composição nutriente estéril, método de cultura de microorganismos, e, substrato de crescimento de microorganismo
Balaganesh et al. Probiotic curd as antibacterial agent against pathogens causing oral deformities–in vitro microbiological study
WO2006132944A3 (en) Probiotic system for aquaculture
Balakrishnan et al. Antibiotic susceptibility of Bacillus spp. isolated from shrimp (Penaeus monodon) culture ponds
AR010140A1 (es) PROCEDIMIENTO DE ANÁLISIS MICROBIOLoGICO Y/O DIAGNoSTICO IN VITRO.
Alavi Predator/prey interaction between Pfiesteria piscicida and Rhodomonas mediated by a marine alpha proteobacterium
ATE353358T1 (de) Milchsäurebakterien der gattung lactococcus lactis und deren verwendung zur konservierung von nahrungsmitteln
ATE423196T1 (de) Antibiotikasensitive milchsäurebakterienstämme
Al-Khafaji et al. comparison the pathogenicity, biofilm and adhesion activity of acinetobacter baumannii isolated from patients using thermoplastic retainer with other oral isolates
Shibata et al. Maintenance of the Microcosm N-System
Azelmat et al. Antibacterial and Anti-inflammatory Activities of Ppc-1, Active Principle of the Cellular Slime Mold Polysphondylium pseudo-candidum
Gupta et al. Preliminary study on inhibitory activity of Enterobacter sp. Strain KD111 isolated from the Cow feces
Aderiye et al. In vivo evaluation of hypolipidemic potentials of Bacillus species isolated from fermented locust bean (Parkia fillicoides Welw) seeds (Iru).
RU2003112420A (ru) Биопрепарат лечебно-профилактического действия при эндометритах животных

Legal Events

Date Code Title Description
FD Application declared void or lapsed